IMDRF 2023

Elodie Baumfeld Andre is currently the Head of Real-World Data (RWD) team at Roche Information Solutions, which supports the diagnostic portfolio including both in-vitro assays and digital health products.

Previously, she was the Real-World Evidence (RWE) Regulatory Strategy Lead at Pfizer, where she focused on generating RWE to support regulatory decision-making, driving innovation in clinical trial design. In her earlier career, she filled a variety of roles across Medical Affairs and Health Economics & Outcomes Research, strategically supporting and positioning Pfizer’s cardiovascular, neuroscience, and pain/inflammation portfolios, leveraging RWD through observational research studies. Elodie also previously served as the Chief of Staff to Pfizer’s Global President of Worldwide Research & Development, advising and providing operational support for some of the company’s key R&D initiatives.

Elodie holds a PhD in Pharmacoepidemiology from the Université de Montréal in Canada, as well as a Master’s in Pharmacology and Bachelor’s degree in Physics from UFR Sciences et Techniques in France.